188Re-HEDP
铼[Re-188]依替膦酸盐
Report date: 2022/07/19 16:22:54
NME
Base Information
Drug Name188Re-HEDP
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Atom Kexing Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesJiangsu Laitai Medical Biotechnology Co LtdShanghai Institute Of Applied Physics, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A